Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Price:
1 867.1
INR
2.08%
Market Closed
Market Cap:
₹4.5T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
IN |
|
Sun Pharmaceutical Industries Ltd
BSE:524715
|
IN |
Wall St Price Targets
SUNPHARMA Price Forecast
Based on 34 analysts
Based on 34 analysts
+17% Upside
from
₹1 867.1
today
Sun Pharmaceutical Industries Ltd (SUNPHARMA)’s 12-month stock price forecast through November 2027 has a consensus target of ₹2 193, implying 17% upside. The forecast is based on price targets from 34 Wall Street analysts.
SUNPHARMA Analyst Rating
No ratings yet
No ratings yet
Sun Pharmaceutical Industries Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUNPHARMA's stock price target?
Price Target
2 193
INR
2 193
INR
According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 193 INR with a low forecast of 1 848.3 INR and a high forecast of 2 558.85 INR.
What is the Revenue forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 14%.
What is the Gross Profit forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 17%.
What is the Operating Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 18%.
What is the Pre-Tax Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 19%.
